HealthcareRequest a quote Sterile injectables · Contract manufacturing enquiry
Discuss third-party manufacturing with Walter Healthcare, India. Confirm the formulation, liquid-injectable presentation, packaging and project requirements for a product-specific quotation.
Catalogue details support an initial B2B discussion. Walter confirms the applicable unit, current licence scope, formula, target market and commercial feasibility before making a commitment.
Editorial development perspective
These notes use the catalogue composition and presentation to frame a technical discussion. They are planning considerations, not tested properties or clinical findings for this product.
A matching clinical reference has not yet been verified for this page. Drug-specific mechanisms and human pharmacokinetic values remain open for review.
Listed presentation: Liquid injectables.
The development discussion should settle the intended route, vehicle, concentration and container before choosing a sterile-processing strategy. Assess formulation–container compatibility and the relevant physical and microbiological controls together. Whether filtration or another process is suitable is a technical decision for the actual product, not an inference from the ingredient name.
Strength expressions in this entry include “150 mg”.
Tie every stated ingredient amount to its intended dosage unit or measure, then distinguish that declared amount from the quantity of raw material needed for a batch. Record any assay or equivalence calculation in the formula. This gives development, purchasing and artwork teams the same strength definition without assigning a patient dose from the catalogue.
A practical starting point is to translate the listed strength into a quantitative formula. For this liquid injectables brief, agree the target characteristics and a short set of measurable development questions before comparing prototypes or supplier proposals. Keep unresolved clinical claims outside the product specification until supporting evidence is available.
Discuss this product briefManufacturing & packaging brief
Use this preparation guide for Aceclofenac 150 mg / ml Liquid injectables. These are the decisions to resolve with the technical team before a site, process and commercial scope are confirmed.
Confirm concentration, fill volume, route and whether the proposed container is single-dose or multidose. Identify the formulation and transfer information available.
Ask for review of the sterile-process strategy, applicable sterility, endotoxin and particulate controls, analytical methods and container-closure integrity requirements.
Review the technical documentsSpecify ampoule, vial or other proposed container, contact materials, closure and secondary pack. Confirm equipment and facility fit for that configuration.
Explore packaging optionsFor Aceclofenac 150 mg / ml Liquid injectables, state the container count and fill volume, target market and reorder forecast. MOQ and lead time depend on the assessed formula, process, components, testing and project readiness; request those terms in writing.
Explore the context
Common questions
Aceclofenac 150 mg / ml Liquid injectables
The catalogue lists Aceclofenac 150 mg / ml as liquid injectables in its pain & musculoskeletal care navigation area and non-beta-lactam manufacturing stream.
No. Walter checks current facility permissions, formulation and equipment fit, testing, packaging and target-market requirements before written confirmation.
Share the exact composition and strength, liquid injectables presentation, target market, initial quantity, preferred pack and timing. Identify whether this is a new product, development brief or transfer.
The quotation must confirm MOQ, inclusions, prerequisites and lead time for the proposed product and site.
Include each proposed pack and country in the enquiry. Container compatibility, artwork, supporting stability evidence, permission scope and destination requirements need review for the requested configuration.
A catalogue record does not establish export registration or a shelf-life commitment.
Use the product-specific enquiry button to carry this composition and dosage form into the form. After a successful submission, a receipt reference confirms that your brief has been saved for review. Use the RFQ checklist to prepare the remaining details.
Technical document review
Ask about manufacturing and packing records, specifications, analytical methods, Certificates of Analysis (COA), stability evidence, the Process Validation Protocol (PVP) and Process Validation Report (PVR). The wider checklist below covers supplier qualification, technical transfer and ongoing supply.
Agree the list for the exact product, site, process, pack, market and project stage. QA confirms what exists, applies and may be shared; some records may require an NDA, redaction or controlled review. See document definitions and review guidance.
Important qualification
This B2B catalogue record is not proof of current approval or confirmation that Aceclofenac 150 mg / ml Liquid injectables is available for sale. It is not prescribing information or patient advice. Any Drugs Rules status, current approval, exemption, applicable unit, licence scope, formulation, claims, brand use, destination-market registration and commercial feasibility require documentary verification and Walter's written confirmation. Read the full regulatory disclaimer.
Composition and classification are taken from Walter's product catalogue. The manufacturing guide helps buyers prepare a technical brief. Clinical references, where shown, describe the cited product and study. Manufacturing guide updated .